laparotomy
Conditions
Interventions
amino acid infusion group
placebo (saline) control
Sponsors
Division of Clinical Research National Health Organization Mito Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: patients scheduled laparotomy(malignant & non-malignant diseases)
Exclusion criteria
Exclusion criteria: patients taking drugs which affect the duration of Rocuronium
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| duration of Rocuronium | — |
Countries
Japan
Contacts
Public ContactKazuhiro Watanabe
National Health Organization Mito Medical Center Department of Anesthesiology
Outcome results
None listed